Ziad joined Biomodex in 2019. He has served as President and CEO since 2020. Ziad has over 20 years in the medical device industry. Prior to joining Biomodex, Ziad served as Vice-President of Regulatory and clinical Affairs at JUUL Labs (Altria acquisition). Previously, he served as Vice President, Pre-clinical, Regulatory and Clinical Affairs for PQ Bypass (Fogardy Institute for Innovation incubation). Ziad further served as Vice President, Pre-clinical, Regulatory, Quality and Clinical Affairs for Altura Medical (Lombard Medical acquisition), Prior to that, Ziad held several senior positions including Vice-President, Regulatory, Quality and Clinical Affairs at Auxogyn (Progyny Merger) and Avinger (IPO (AVGR) NASDAQ). Past positions include Director positions with Codman (J&J) and Evalve (Foundry Group incubation – Abbott acquisition) and Guidant (Abbott acquisition). Ziad received both a BS and BA from McGill University and a J.D. from Rutgers University.
David joined Biomodex in 2020 as Vice-President of Research and Development. David has over 30 years’ experience in medical device development, working with KOLs on ground-breaking inventions in a variety of fields including digital mammography, nuclear medicine imaging and OR, wearables and arterial measurements. David has a BSc in Electronic Engineering from Abertay University in Scotland where he also did post-graduate development in fetal ultrasound.
Bill joined Biomodex in 2020 as Vice President of U.S. Sales. Bill is an accomplished sales professional that has won multiple individual awards while also showing the ability to build and develop strong teams. He has held multiple sales and leadership roles over the last 20 years with companies such as Frito-Lay, Boston Scientific and Corindus Vascular Robotics. At Corindus Bill played an integral part in developing the sales team and growing the vascular robotic space that ultimately led to the acquisition by Siemens Healthineers. Prior to starting his sales career Bill played professional baseball and earned a Bachelor of Science degree in Microbiology from the University of South Florida.
Anne-Charlotte joined Biomodex in 2019 as Group Finance Director. Anne-charlotte has over 15 years of progressive leadership experience driving scalable finance organizations, processes, and infrastructure in the US and in Europe. Prior to joining Biomodex, Anne-charlotte worked at SpineGuard (Euronext Growth Paris: ALSGD), a medical device company based in France and the US, for 10 years. Prior to SpineGuard, Anne-Charlotte held various positions at SpineVision, Theradiag (Euronext Growth Paris: ALTER), and Dräger Medical (DAX: DRW3). She received a Degree in International Marketing and Finance from INSEEC, Paris (France) and a Bachelor of Science from Boston College.
Stéphane joined BIOMODEX in 2018 and currently serves as Global Vice President of Operations leading the French and the US production facilities. Stéphane has over 15 years of experience leading operations team in various industries, Prior to joining Biomodex, Stephane held various positions with TOTAL in petroleum, PSA Peugeot Citroen and CLN Group in automotive industry and STENTYS in medical device industry. Previously, Stéphane worked for an International automotive manufacturer where he led the Operation at a production facility with 100 team members.